ORF_ID	Contig	Start	Stop	Orientation	Cut_Off	Pass_Bitscore	Best_Hit_Bitscore	Best_Hit_ARO	Best_Identities	ARO	Model_type	SNPs_in_Best_Hit_ARO	Other_SNPs	Drug Class	Resistance Mechanism	AMR Gene Family	Predicted_DNA	Predicted_Protein	CARD_Protein_Sequence	Percentage Length of Reference Sequence	ID	Model_ID	Nudged	Note
BGC0000834.1|Novobiocin_1 # 3 # 89 # 1 # ID=1_1;partial=10;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.713	BGC0000834.1|Novobiocin_1 	3	89	+	Loose	500	19.2458	mphG	50.0	3003742	protein homolog model	n/a	n/a	macrolide antibiotic	antibiotic inactivation	macrolide phosphotransferase (MPH)	GGTCGCGTCTGGTCGGACAGCTTCGAAAGGGCGGGGAAACGGCGCCACTCCGGTGAGGCCGACGGCAGGGGACGCGACCCCCGTTGA	GRVWSDSFERAGKRRHSGEADGRGRDPR	MKNRDIQKLAERNGLILSDEMSFNEMGIDFKVGFATDRDGTKWLLRIPRRTTLGEQIANEKRILQLVSKYLSVQVPDWRIANEKLVAYPLLDGKPALTYDAETYEVTWNMSKENDLYIPSLAKALIELHSIPTEEVLRNNLKILTPEQVRNEISERLILVKSELGINAELELRYQKWLDNDALWPNFTKFIHGDLYAGHTLTHHNGEVCGIIDWSTAQVSDIAQDFSGHVTVFGEESLKNLIAAYEKQGGEVWDKLFEQAVERAAAAPLAYGYFALETQDEIHLSSAKLQLGVE	9.52	gnl|BL_ORD_ID|2088|hsp_num:0	2259		
BGC0000834.1|Novobiocin_2 # 55 # 654 # 1 # ID=1_2;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.628	BGC0000834.1|Novobiocin_2 	55	654	+	Loose	550	24.2534	LRA-17	34.88	3002512	protein homolog model	n/a	n/a	cephalosporin; penam	antibiotic inactivation	subclass B3 LRA beta-lactamase	GTGAGGCCGACGGCAGGGGACGCGACCCCCGTTGACAGCGGACAACCGAGCGACACCACGTATGGCGGCCTGGAAGTCTCGGCCGAGAGGACCAGACTTCGGATCCCGCGGGACCTCTCCTTGGAGGCCTGGTGCCGTCTCGGCGGAAGGATCCTCGCGGTGTGCGATTCATCGGTGTGGTGGATCGGCGACTGGCTGGTGTTCGGACAGAACCAATACGGTGACCGATACCGCCGGGCGATGAAAGAGACCAAGCTCGACTACCAGACACTGCGCAATTACGCCTGGGTGGCGAGAAAATTCGAGCCGTCTCGCCGGCGAGACAGCCTCACGTTCCAACATCACATGGAAGTGGCGGCTCTCTCGGAAGCCGAACAGGACCACTGGCTCGATTTCGCGGTCCGACTGAATTGGTCGAGGAACGAGCTGCGCAAACAGATCCGGGCCAGCTTGTCGGGCGAAGAAGACGACCTCCGGTGCGAGGTCCAACTCAACCTCCAGTTGGACGAGTTACGTCTCGAACGGTGGAGGGAGGCGGCGCGGGGGAGCAATCTGACTCTGACGGACTGGATCCTGTCCGTCGTGGACGGGGCCGTTTGA	MRPTAGDATPVDSGQPSDTTYGGLEVSAERTRLRIPRDLSLEAWCRLGGRILAVCDSSVWWIGDWLVFGQNQYGDRYRRAMKETKLDYQTLRNYAWVARKFEPSRRRDSLTFQHHMEVAALSEAEQDHWLDFAVRLNWSRNELRKQIRASLSGEEDDLRCEVQLNLQLDELRLERWREAARGSNLTLTDWILSVVDGAV	MSIFRTILFVSILLLTSLANSPHATAQVTNTDRPEWSKPYKPFRIAGNIYYVGTYDLACYLITTPQGHILINAALAGTVDQVKANVEALGFKFSDIKILLISQAHFDHVGGLAAIQKMTGAKVMIDDQDAPVVEDGGNSDYIYGGKGVGSLFAPVHVDRKLHDHDNITLGGTQLEMLHHPGHTKGSCSYLLTVKDEHRSYRVLIANIPYMLSEVTLPGMPTYPNVGKDFMYTYGAMRKLQFDIWVAAHSSQFGLQDVRKETDGYNPGAFGDKKKYLTTIDKTEDIYKEHFKGGK	67.69	gnl|BL_ORD_ID|831|hsp_num:0	883		
BGC0000834.1|Novobiocin_4 # 2131 # 2880 # 1 # ID=1_4;partial=00;start_type=ATG;rbs_motif=GGGT;rbs_spacer=10bp;gc_cont=0.724	BGC0000834.1|Novobiocin_4 	2131	2880	+	Loose	2200	26.9498	rpoB2	25.42	3000501	protein homolog model	n/a	n/a	rifamycin antibiotic	antibiotic target alteration; antibiotic target replacement	rifamycin-resistant beta-subunit of RNA polymerase (rpoB)	ATGCACCGGCTGTGGGCGGCTCGTTTCCGAGGCGACGAATCGATCGAGGTCGTATTCGTCGACGGCTCCCCGGCCGATGTGTTCGTTCTCGCGGTCGAGTTGAACCGTGCGCACGGCCTGCCGCTCACGCTGGACGAGCGCAAATCCGCCGCCGCCCAGATCATGGATTCACACCCGCACTGGTCCGACCGCAAGATCGCACGGACCACCGGACTGGCGGCCAGCACCGTCGCGTCGCTGAGGTCGTCGTCCACCGCCGGCACGGTCGGGCGCAGGACCGGCCAGGACGGCCGGAGCCGGCCCAACGACGGTACGGACGGACGGCAGCGCGCCGCCGCCCTGCTGGCCCGGAATCCGAACGCGTCGCTTCGCGAGGTGACCAGAGCCGCGGGGATCTCGGTCGGCACCGCCAGCGATGTGCGCGCCAGACTGCGGCGGGGGGAGCCGGCGCTCACCGCCCGGCAGCAGGCCGTGATGAAACTGCGCCCCGCCGCGGCTCAGCGGAGCGGCCCGGACTACGGCCGCGTACTGGAAAACCTGCGCAAGGACCCGTCGCTGCGCTTCACCGACCTCGGCCGGCGCCTGCTCCGCCTGCTCGACGGCTCCGTCCCCGGCAGTGTCGAGCAGATCGCCCAGATCGCGGACGGCGTGCCGGAACACTGCCGGACCGTGGTGGTCGACATGGCCCGCGAGTGCGCCGCCGCCTGGCAGCATCTCGCCGACCAGCTCGCCGACCGGGACACCGCCTGA	MHRLWAARFRGDESIEVVFVDGSPADVFVLAVELNRAHGLPLTLDERKSAAAQIMDSHPHWSDRKIARTTGLAASTVASLRSSSTAGTVGRRTGQDGRSRPNDGTDGRQRAAALLARNPNASLREVTRAAGISVGTASDVRARLRRGEPALTARQQAVMKLRPAAAQRSGPDYGRVLENLRKDPSLRFTDLGRRLLRLLDGSVPGSVEQIAQIADGVPEHCRTVVVDMARECAAAWQHLADQLADRDTA	MLEGRIVTVSSRTESPLAAPGVPGAPRRLSFARIREPLAVPGLLDIQTESFGWLIGAPDWCARAAARGTEPVAGLAEVLAEISPIEDFAGTMSLTLSDPRFEEVKASVEECKDKDLTYAAPWFVTAEFVNNNTGEIKSQTVFMGDFPMMTAHGTFVVNGTERVVVSQLVRSPGVYFDHAIDKGSEKDVHSARVIPSRGAWLEFDVDKRDTLGVRIDRKRRQPVTVLLKALGWSAERIAERFGFAPLIMASLAKDNVAGTDDALLEIHRKLRPGEPPTKESAQNLLANLFFTEKRYDLARVGRYKIDKKLGLRAPGAPRVLTEDDIAATIEYLVRLHAGERTMIAPGGVEVPVEVDDIDHFGNRRVRTVGELIQNQIRVGLSRMERVVRERMTTQDVEAITPQSLMNIRPVVAAMKEFFGTSQLSQFMDQRNPLASLTNKRRLSALGPGGLSRERAGLEVRDVHYSHYGRMCPIETPEGPNIGLMGYLSVYARVNPFGFVETPYRRVVDGRVTDEVDYLTADEEDRHVVAQANEPLDAEGRFLAARIPVRRKNSEVELVDSAAVDYMDVSPRQMVSVATAMIPFLEHDDANRALMGANMQRQAVPLIRSEAPIVGTGMELRAAVDAGDVVVNEKAGVVEEVSADYVTVMADDGTRKSYRMRKFNRSNQGTCSNQRPIVDEGQRVEAGQVLADGPCTENGEMALGKNLLVAIMPWEGHNYEDAIILSQRLVEQDVLTSIHIEEHEIDARDTKLGAEEITRDIPNVSDEVLADLDERGIVRIGAEVRDGDILVGKVTPKGETELTPEERLLRAIFGEKAREVRDTSLKVPHGESGKVIGIRVFSREDDDDLPPGVNELVRVYVAQKRKIQDGDKLAGRHGNKGVIGKILPTEDMPFLPDGTPVDIILNTHGVPRRMNIGQILETHLGWIGKAGWKVEGNPEWAKDLPEEMWEAPADSNIATPVFDGAREEELTGLLGSTLPNRDGERMVDDNGKAVLFDGRSGEPFPYPVAVGYMYILKLHHLVDDKIHARSTGPYSMITQQPLGGKAQFGGQRFGEMECWAMQAYGAAYTLQELLTIKSDDVVGRVKVYEAIVKGDNIPEPGVPESFKVLLKELQALCLNVEVLSAGAAVELAHGVDDDHERTAANLGINLSRAESITETELSG	21.43	gnl|BL_ORD_ID|2485|hsp_num:0	2831		
BGC0000834.1|Novobiocin_5 # 3076 # 4878 # 1 # ID=1_5;partial=00;start_type=TTG;rbs_motif=AGGGG;rbs_spacer=5bp;gc_cont=0.694	BGC0000834.1|Novobiocin_5 	3076	4878	+	Loose	550	26.9498	KPC-15	40.82	3002325	protein homolog model	n/a	n/a	monobactam; carbapenem; cephalosporin; penam	antibiotic inactivation	KPC beta-lactamase	TTGTTCAACACACGTGCGAACAAAGCTTCTGATCAGTCGCCGACAATACCGACGGAATCGGCCACCCTGGCCGAACTCTGGGAGCGGACGGTACGAAGTCGGCCGAGCAGCCCGGCAATTGTCACCAACGGCGAGACCCTGTCCTACGACGAGGTCAACGCCAGGGCGAACCGGCTGGCACGACTGCTGCTCGACGAGGGGGCGGGCCCGGGCCGTCTGGTGGCACTGGCGCTGCCCCGCTCCAGTCATCTGGTGATCAGCGTGCTTGCCGTGGCCAAGGCCGGCGCGGTGTTCCTGCCGCTGGACGTCAACCACCCGCGGGAGCGGCTCTCGTACCAACTCGCCGATGCCCGGCCCGCGTTGCTGTGCACCGTCCGAAGCGCCGCCGCGAGACTGCCGGACGGCATCGAGATGCCGCGGGTGCTGCTGGACTCGCCCGAGCGCACCGCCGTACTCGACGCACTGCCCGACACCGACCTGACCGACGACGAACGCGGCGGACCGCTCGCCGCGACGGACCTGGCCTACGTGATCTACACCTCCGGCTCGACAGGCCGGCCGAAAGGCGTCGCGCTGACCGGCGCCGGGTTGCCGGCCCTGGCAGCGGCCAAGGTCGCCGCGATGCGGGTCACCGGGGACAGCCGGGTGCTCCAGTTCGCGTCGCCGGGCTTCGACGCCTACCTGACCGAACTGCTGGCCGCGTTCACCGCCGGTGCCACTCTCGTGGTGCCGGGAACGGACACGCTCGCCGGTGACCCGCTGCGAAGGGCCTTGCGGGACGGCCGGGTGAGCCACGCTGTGCTGCCGCCCGCGGCGGTCGCGACCATGTCCCCGGACGCGGTGCCCGACCTGCGCGTGCTGGTGGTGGCGGGCGAGGCGTGCCCGGCCGGCCTGGTCGAACGGTGGGCGCCCGGCCGCCTTCTGATCAACGCCTACGGTCCGACCGAGTGCACGGTGTGCGCGACCATGACCGGCCCGCTCACCCCGACGGACGAGGTCACCATCGGCCGGCCGATTCCCGGCGTGTCCGTGTACATCCTCGACGCCGAACGACGCCCGGCCGCGCCCGGAGAGATCGGCGAGTTGTACCTCAGCGGTGCCGGGCTGGCCCAGGGCTACCTCAACAGCCCCGACCTGACGGCCCAGATGTTCGTACCCAACCCGTTCGCCGCCGACGGCGAACGGATGTACCGCACGGGCGATCTGGCCTCCAGGCGGGCCGACGGCGACATCCTCTTCCACGGCCGGATCGATGATCAGGTCGAACTGCGCGGATTCCGCGTCGAGTTGGGAGAGGTGGAGTCCGTACTCAGCCAACATCCGGACGTGGCACAGGCGGTGGCCGCGCTGTGGACCGATCCGGCCGAGGGGCCGCAGTTGGTGACGTACGTCGTCCCGGCACCCGGCACCACGCCGTCGGCGGGCGAACTGCGTGAGCACGCCGGCCGCTTCCTGCCCGACTTCATGGTGCCGTCGGCATTCACGACCATCGACGCCGTTCCCCTGACTCCCGGCGGAAAGACGGACCGGGCCGGGCTGCCGGATCCGGTGAAAGCCACCCAGCCTGCCGGACTTGGCCCGCGTACTCCTGCCGAGAAGGTCCTCTGTGACATATTCCGGGACCTGTTCGACCTTGTTGAGATCGACGTGCGCAGTAATTTCTTCGAAATGGGCGGGAACAGCATTCTGGCTGTCGACCTCATTCAGCGAGCGCAAGAAGCCGGCTTGACGCTCATGCCGAGGACCGTGATCGACCACCCCACCATCGAGCAACTGGCCGCGATAGCGACCCTCGAGGAGTGA	MFNTRANKASDQSPTIPTESATLAELWERTVRSRPSSPAIVTNGETLSYDEVNARANRLARLLLDEGAGPGRLVALALPRSSHLVISVLAVAKAGAVFLPLDVNHPRERLSYQLADARPALLCTVRSAAARLPDGIEMPRVLLDSPERTAVLDALPDTDLTDDERGGPLAATDLAYVIYTSGSTGRPKGVALTGAGLPALAAAKVAAMRVTGDSRVLQFASPGFDAYLTELLAAFTAGATLVVPGTDTLAGDPLRRALRDGRVSHAVLPPAAVATMSPDAVPDLRVLVVAGEACPAGLVERWAPGRLLINAYGPTECTVCATMTGPLTPTDEVTIGRPIPGVSVYILDAERRPAAPGEIGELYLSGAGLAQGYLNSPDLTAQMFVPNPFAADGERMYRTGDLASRRADGDILFHGRIDDQVELRGFRVELGEVESVLSQHPDVAQAVAALWTDPAEGPQLVTYVVPAPGTTPSAGELREHAGRFLPDFMVPSAFTTIDAVPLTPGGKTDRAGLPDPVKATQPAGLGPRTPAEKVLCDIFRDLFDLVEIDVRSNFFEMGGNSILAVDLIQRAQEAGLTLMPRTVIDHPTIEQLAAIATLEE	MSLYRRLVLLSCLSWPLAGFSATALTNLVAEPFAKLEQDFGGSIGVYAMDTGSGATVSYRAEERFPLCSSFKGFLAAAVLARSQQQAGLLDTPIRYGKNALVRWSPISEKYLTTGMTVLELSAAAVQYSDNAAANLLLKELGGPAKLTAFMRSIGDTTFRLDRWELELNSAIPGDARDTSSPRAVTESLQKLTLGSALAAPQRQQFVDWLKGNTTGNHRIRAAVPADWAVGDKTGTCGGYGTANDYAVVWPTGRAPIVLAVYTRAPNKDDKYSEAVIAAAARLALEGLGVNGQ	204.78	gnl|BL_ORD_ID|871|hsp_num:0	926		
BGC0000834.1|Novobiocin_6 # 4882 # 6105 # 1 # ID=1_6;partial=00;start_type=ATG;rbs_motif=AGG;rbs_spacer=8bp;gc_cont=0.664	BGC0000834.1|Novobiocin_6 	4882	6105	+	Loose	680	27.335	LpeA	28.0	3004099	protein homolog model	n/a	n/a	macrolide antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGAGCACCCGTCCCACGGTGTCCCCCAGCGAACTCGAACAGATCGACCTGGCATCACCGGTCCTGCACGCCGAGTACGAACTGGACGAGATCTTCCGCCACCTGCGCGCCGATGAGCCGGTGTACTGGCAGCAGCCACGGAACGAGCAGCCCGGCTTCTGGGTGATCAGTCGCCACGCCGACGTGAACGAGGTGTACAAGGACAAGGAGCACTTCACGACGGAGCACGGCAACGCGCTGGCCACTTTGCTGACCGGCGGTGACTCTGCCTCGGGCGCCATGCTCGCCGTCACCGACGGAGTGCGCCACCATCAGGTGCGCAACGTGTTGTCCAGGGGCTTCTCGGCGCGGATGCTCGACCTCATCGCCCACACGCTGCAGGAAACCGTGGACGGTCTGCTGCTGGCGGCACTGGAGCGAGGCGAATGCGACGCCGCGCAGGACATCGCGGCGGACGTGCCACTCGGGGCGATCTGCGACCTGCTGGAGATTCCCCACGCGGACCGGAAGTACCTGCTCGGTCTGACCTCGCACGCGTGGAGCACGGACTACGCGGACGAGCCTCCCGAGGAGAGCTGGGTCGCCAAGAACGAGATCCTGCTGTACTTCAGCAAGCTGCTCAAGGAGCGTCGCGGTGGAGTCCGGGAGGACATGGTCAGCCTGCTGGCGAACTGCCGGATCGACGGCGATCCGCTCAAGGCGGCCGAGCAGATGGCCAACTGCTACGGGCTGATGATCGGCGGCGACGAGACCGGCAGGCACGCCATCACCGGCACGATCCTCGCGTTGATCCAGAACCCCGACCAGTGGCGTGCGCTGAAGAACGGCGACGTCGATCTGAACACGGCGACCGAGGAGGCCCTGCGCTGGACCGTGCCGTCGCTGCACGGAGGCCGGAAGGCGACCGGAGACGTCGTGATCAACGGCCGGCGGATCAACGCCGGCGATGTGGTCAGTGTGTGGATCTCCTCGGCCAACCGTGACGAGACCGTCTTCGACGCGCCGGACGAGTTCAACCTCGCCCGCACCCCGAACAAGCACTTCACCTTCGCGTACGGCTCGCACTACTGCCTCGGCCACTACCTCGGCCGGATGGAGGTCTACGCCGTGCTCGACGGGCTGCGCCGGCTGGTGGGCGACCTGGAGCAGATCGGCGAGGAGCGATGGATCTACTCCAGCATCCTGCACGGGATGAGCTCACTGCCGATCAGGATCACGGGCTGA	MSTRPTVSPSELEQIDLASPVLHAEYELDEIFRHLRADEPVYWQQPRNEQPGFWVISRHADVNEVYKDKEHFTTEHGNALATLLTGGDSASGAMLAVTDGVRHHQVRNVLSRGFSARMLDLIAHTLQETVDGLLLAALERGECDAAQDIAADVPLGAICDLLEIPHADRKYLLGLTSHAWSTDYADEPPEESWVAKNEILLYFSKLLKERRGGVREDMVSLLANCRIDGDPLKAAEQMANCYGLMIGGDETGRHAITGTILALIQNPDQWRALKNGDVDLNTATEEALRWTVPSLHGGRKATGDVVINGRRINAGDVVSVWISSANRDETVFDAPDEFNLARTPNKHFTFAYGSHYCLGHYLGRMEVYAVLDGLRRLVGDLEQIGEERWIYSSILHGMSSLPIRITG	MLGIQFNRGQWRSNYYWQIPVLIIAVISILFFISKKLFYSKVTPESIPNKLVEVEPIKSHNLQQTIHLLGTIHPKHATTLIAKESGMLDTLIPTGQKVTKGTLIAKINNPDLEKNLQLSLSAVELAKAQYERITPLIKSGYVSTKEVEEKKQAWIDAQKELSKTRIELDNLRFYAPFDGIIGAYKKREGAQVNAGESVVSIYDPSALVVDFDIPCSNLATLNEGQPVYVLGKRYSLSHLQKMLDEDTHMCPADVDIQCDDCLIGATTSVELLVAEKNNTIVIPFQAIFLRNSKPFVYLVKKGKIVLASVKTGLQQEDKIEIVEGLKAGQQLVTKGQERLYPEMTVDIYHPATSSS	114.65	gnl|BL_ORD_ID|2453|hsp_num:0	2758		
BGC0000834.1|Novobiocin_7 # 6119 # 6913 # 1 # ID=1_7;partial=00;start_type=GTG;rbs_motif=AGGGG;rbs_spacer=9bp;gc_cont=0.721	BGC0000834.1|Novobiocin_7 	6119	6913	+	Loose	700	26.5646	CMY-72	35.9	3002085	protein homolog model	n/a	n/a	cephamycin	antibiotic inactivation	CMY beta-lactamase	GTGCGGATGACGAGCCCGGCCGATGCGACCACCGAAGTCGCTGTGTCTCAGGAGTCGGTCGCCATGGTCACCGGAGCCGGCCGGGGCATCGGCGCGGCCACGGCCGAGCGCCTCGCCGCCGAGGGCATGGCGGTGATCGTCGTGGACCGCACCGAACAGGACACCCGGGCCACGGTCGCGGCCATTCGCACGGCCGGCGGACGGGCCCGCGGGATCGGCTGTGACGTCGCCGTGGCCCAGGCCGTGACGGCCGCGGTCGCCACGGCCGTCGAGGAGTTCGGCCGCATCGACGTACTGGTGAACTGCGCCGGGATCAACCGGGACCGGCTGCTGCTCACCATGGGCGATCAGGAGTGGGACACGGTCCTGGACGTCAACCTCGGCGGCACCATGCGATGTTCGTTCGCCGTCGGCCGGCACATGCGCCGGCAGGGGCACGGCCGGATCATCAACTTCAGCTCCGTGGCCGCGCGCGGCAATGCCGGCCAGACCAACTACGCGACCGCCAAAGGCGCGATCGCCGGGTTCACCCGTACGCTCGCGGCCGAACTGGGCCCGCACGGCGTGACGGTCAACGCCATCGCACCGGGCTTCGTGGCCACGCCGATGGTGGACGAGCTGGCCGAACGGCTCGGCGGGGACCGGGACTCGGTCATGTCGGAGGCGGCGAAGTCCTCGGCAGTGGGCCGGATCGGGACGCCCGAGGAAATCGCCGCGACCGTGGTCTTCGTCGCCCGGCCGGAATCGGGCTACCTCACCGGCGAGACCGTTCACGTCGACGGCGGTCGGCCATGA	MRMTSPADATTEVAVSQESVAMVTGAGRGIGAATAERLAAEGMAVIVVDRTEQDTRATVAAIRTAGGRARGIGCDVAVAQAVTAAVATAVEEFGRIDVLVNCAGINRDRLLLTMGDQEWDTVLDVNLGGTMRCSFAVGRHMRRQGHGRIINFSSVAARGNAGQTNYATAKGAIAGFTRTLAAELGPHGVTVNAIAPGFVATPMVDELAERLGGDRDSVMSEAAKSSAVGRIGTPEEIAATVVFVARPESGYLTGETVHVDGGRP	MMKKSICCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAIIYEGKPYYFTWGKADIANNHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQWRGISLLHLATYTAGGLPLQIPDDVTDKAELLRFYQNWQPQWTPGAKRLYANSSIGLFGALAVKSSGMSYEEAMTRRVLQPLKLAHTWITVPQSEQKNYAWGYLEGKPVHVSPGQLDAEAYGVKSSVIDMARWVQANMDASHVQEKTLQQGIELAQSRYWRIGDMYQGLGWEMLNWPLKADSIINGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLANKSYPNPARVEAAWRILEKLQ	69.29	gnl|BL_ORD_ID|1174|hsp_num:0	1247		
BGC0000834.1|Novobiocin_8 # 6910 # 7644 # 1 # ID=1_8;partial=00;start_type=ATG;rbs_motif=GGT;rbs_spacer=5bp;gc_cont=0.740	BGC0000834.1|Novobiocin_8 	6910	7644	+	Loose	600	25.0238	TriB	35.56	3003680	protein homolog model	n/a	n/a	triclosan	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGACACGAGTGGCGGTCGTGGCCGGCGGCGGCGAGCACACGGGGCCCGCGGTCGCGCTCAGGCTGGCGGCGGGGGGCTTCGACGTCGCCCTGCTGGGCTCCGAGTTCACGTCGGCCGACAAGACGGTCAGGCGCGTCGAGGAGTACGGCAGGCAATGCGTCACCGTGCGGGCCGAGTTGAGCGACGCCAGATCCGTCGCGGTCGCCTTCGGCCGGGTACGTACGGCGTTGAGCGGCCCGGCCGTACTGGTCACCTGCGTCGGACCGCAGCCGCTGCCGGACGGGTTGCCCGAGGACGAGAGCGCGGACGAACAGCGCTACACGGCGGTACGGCGGGCGCTGCGCCCGGTGTTCGTGTGCTGCCAGGCCGGGGCCGGCCAGCTGCTGCGCCACCGGTGGGGACGGATCATCATCGTCACCGAGCCGGCCGACGCCGACGGGAACACCTGGCGCACCAGCCGGCCGGTGCTCGACGGGCTGATCGGTTTCACCCGGTCCGCGGCGCTGGAGCTGGCGAGGTCCGGGACCACCGTGAACCTCGTCGCTCCGGCCGACCGCGCCGCCGACAGCCGGGCCCCGGCCCACCGGGCGGCGGGCGACGACAGCGCGGGCTCCTACGCGGACGGGGTCGCGCACGTGACGGAGTTCCTGGTCGACGAGCGAGCCGTCGGAATCACCGGGCAGGCGATCCGTGTCGCCGCCCGGGCGGACGTACCTCTACTTCGCGAAAGGTAG	MTRVAVVAGGGEHTGPAVALRLAAGGFDVALLGSEFTSADKTVRRVEEYGRQCVTVRAELSDARSVAVAFGRVRTALSGPAVLVTCVGPQPLPDGLPEDESADEQRYTAVRRALRPVFVCCQAGAGQLLRHRWGRIIIVTEPADADGNTWRTSRPVLDGLIGFTRSAALELARSGTTVNLVAPADRAADSRAPAHRAAGDDSAGSYADGVAHVTEFLVDERAVGITGQAIRVAARADVPLLRER	MKPFSLAGLFGFALLLSGCGDEPPPAPPRPVLTVTVKTLKNDDLGRFAGSIQARYESVLGFRTNGRIASRLFDVGDFVGKGALLATLDPTDQQNQLRASQGDLASAEAQLIDAQANARRQEELFARSVTAQARLDDARTRLKTSQASFDQAKAAVQQARDQLSYTRLVTDFDGVITTWHAEAGQVVSAGQAVVTLARPEVREAVFDLPTEVAESLPADARFLVSAQLDPQARTTGSIRELGPQADASTRTRRVRLSLAQTPEAFRLGSTIQVQLSSAGSVRSVLPASVLLERDGKTQVWVVDGKQSSVALREVQVLSRDERQVVIGQGLADGDRVVRAGVNSLKPGQKIKLDEDAR	68.54	gnl|BL_ORD_ID|2048|hsp_num:0	2193		
BGC0000834.1|Novobiocin_9 # 7651 # 9234 # 1 # ID=1_9;partial=00;start_type=GTG;rbs_motif=AGGT;rbs_spacer=8bp;gc_cont=0.703	BGC0000834.1|Novobiocin_9 	7651	9234	+	Loose	1050	28.1054	YojI	45.45	3003952	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic efflux	ATP-binding cassette (ABC) antibiotic efflux pump	GTGGCGAACAAGGATCACGCACCGGAGCACTACGTCACCCGCATCCTCGCCGAGGCGACCCTTGACGGCGCGCGACCGGTCGTCCGGTGGCGGGACACGGTCATCACCGGCACCCAACTCGACCGATCGGTACGGCGCGTCGTGACGGCACTGCGCGAGGCAGGTGTGGCACGCGATCACGCGGTGGCCGTCCTGACCCAGGTCAACAGTCCATGGATGCTGATCGTCCGCTACGCCGCGCACCTGGTGGGCGCGTCGGTCGTGTACATCACCGGCGCCAACCACGGCATCGTGACGCACGAACTGCCGGTGGCCACCCGGGTCCGGATGCTGCGTGAAGCGGGCGCGTCGGTGCTGGTGTTCGACGAGAGCAACGCCCAACTCGCCGAGACCGTCGACGAGACGGTGCGGGACAAGCTGGTGCTGTGCGGCCTCGGTCATCCGGCGTCCGGCACGGTGAGCGTCGACGGCCGGCCTGTCGATGACGTCTCGGTGGACTTCACGCCCGAGGCGCCCGAGCTGGCCATGGTGCTCTACACCAGCGGCACCACCGGTCAACCCAAGGGCGTGTGCCGGTCGTTCGGGTCGTGGAACGCGGCGGCGCTCCGCGGGGCGGCGTATCCCCGGCCGGTCTTCCTGACAATGACCGCGGTGAGCCAGACAGTCGCGATGATCGTCGACACGGTGCTGGCCGCCGGCGGGAGCGTGCTGCTGCGCGAGAGGTTCGATCCCGCCGACTTCCTGCGGGATGTCGGAGAGCACCGCGTCACCGAGACGTTCATGGGCGTGGCGCAGCTCTACGCGATCCTCGGGCACCCGGACGCTCGTACCGCGGACCTGTCCTCGTTGCGCCACGTGTTGTATCTCGGCTGCCCCGCGTCACCGGAACGCCTGCGGGAGGCGGCCGCACTGCTGCCCGGCGTACTGGCCCAGTCGTACGGCTCCACCGAGGCCGGCCGGATCACGGTGCTCCGCGCGGCCGACCACGAACGTCCGGAACTGCTGGCCACCGTGGGCCGGGCGGTGCCGGGGGTCACCATCGCCATCCGCGACCCGGAAACAGGACACGACCTGCCGGTCGGCGAGATCGGCGAGGTCGTGGTGCACGGCCCGGAGGTCATGGCCGGCTATGTCGCCGATCCCGAGCACACCGCGCGGGTGATCCGGGACGGCTGGGTGCACACCGGCGACTTCGGTTCCGTCGACGAACGCGGGTACGTGCGGCTGTTCGGCCGGATGCGCGAGGTGGTCAAGGTGCAGGACACGCGGGTCAGTCCGACCGAGGTGGAGAAGGTGCTCGTCGGCTGTCCCGGTGTGGTCGACGCGTGCGTGTACGGCCACCGCGGGCCGGACCTCATCGAGGAACTGCACGCCGCCGTCGTACTGGGCACCGAGGGCGCTCCGAGCTTTGACACTCTGCGCGACCACGTCGCCCGGGCCATGACCCCGACACACGCCCCGATCCGGTTCGTACGGTGGCGGCGGTTCCCGATCAACAACACCGGCAAGGTGAATCGGCTGCGGGTCCGAGAGGTCAGCGCCGAGGCCCGCGGTGACAGCCCGGACGTCCTGGTGGACAGGTGA	MANKDHAPEHYVTRILAEATLDGARPVVRWRDTVITGTQLDRSVRRVVTALREAGVARDHAVAVLTQVNSPWMLIVRYAAHLVGASVVYITGANHGIVTHELPVATRVRMLREAGASVLVFDESNAQLAETVDETVRDKLVLCGLGHPASGTVSVDGRPVDDVSVDFTPEAPELAMVLYTSGTTGQPKGVCRSFGSWNAAALRGAAYPRPVFLTMTAVSQTVAMIVDTVLAAGGSVLLRERFDPADFLRDVGEHRVTETFMGVAQLYAILGHPDARTADLSSLRHVLYLGCPASPERLREAAALLPGVLAQSYGSTEAGRITVLRAADHERPELLATVGRAVPGVTIAIRDPETGHDLPVGEIGEVVVHGPEVMAGYVADPEHTARVIRDGWVHTGDFGSVDERGYVRLFGRMREVVKVQDTRVSPTEVEKVLVGCPGVVDACVYGHRGPDLIEELHAAVVLGTEGAPSFDTLRDHVARAMTPTHAPIRFVRWRRFPINNTGKVNRLRVREVSAEARGDSPDVLVDR	MELLVLVWRQYRWPFISVMALSLASAALGIGLIAFINQRLIETADTSLLVLPEFLGLLLLLMAVTLGSQLALTTLGHHFVYRLRSEFIKRILDTHVERIEQLGSASLLAGLTSDVRNITIAFVRLPELVQGIILTIGSAAYLWMLSGKMLLVTAIWMAITIWGGFVLVARVYKHMATLRETEDKLYTDFQTVLEGRKELTLNRERAEYVFNNLYIPDAQEYRHHIIRADTFHLSAVNWSNIMMLGAIGLVFWMANSLGWADTNVAATYSLTLLFLRTPLLSAVGALPTLLTAQVAFNKLNKFALAPFKAEFPRPQAFPNWQTLELRNVTFAYQDNAFSVGPINLTIKRGELLFLIGGNGSGKSTLAMLLTGLYQPQSGEILLDGKPVSGEQPEDYRKLFSAVFTDVWLFDQLLGPEGKPANPQLVEKWLAQLKMAHKLELSNGRIVNLKLSKGQKKRVALLLALAEERDIILLDEWAADQDPHFRREFYQVLLPLMQEMGKTIFAISHDDHYFIHADRLLEMRNGQLSELTGEERDAASRDAVARTA	96.34	gnl|BL_ORD_ID|2264|hsp_num:0	2424		
BGC0000834.1|Novobiocin_10 # 9248 # 10387 # 1 # ID=1_10;partial=00;start_type=ATG;rbs_motif=AGGT;rbs_spacer=10bp;gc_cont=0.732	BGC0000834.1|Novobiocin_10 	9248	10387	+	Loose	700	64.3142	oleI	25.45	3000866	protein homolog model	n/a	n/a	macrolide antibiotic	antibiotic inactivation	ole glycosyltransferase	ATGAGAGTGCTGTTGACGAGTCTGCCCGGCATCGGCCACCTGTTTCCCATGGTGCCGCTGGGCTGGGCGCTCCAGGCGGCCGGGCACACCGTCCTGGTCGCCACGGACCGGGAGTTCCTCCCGGTGGTGACCGGGGCGGGACTGTCCGCCACGGCCGTACTGGACCCGGTCGACCCGGTCGAGCTGTTCAAACCGGTCGAACCGTTCGGCGATCCGCTGAGCCCGGCCGAGCGGACCGGGCACCGGTGCGCCGAGGCCGGTGTCCGGGCGCTGCCCGCCATGCGCGCACTCGTGGACGTGTGGCACCCGGACCTGGTGATCGCCGAGCCCATGGAGCTGGCCGGGCCCGCCGCGGCGACGAATGCCGGGGTGCCCTGGGTACGGCACTCCTACGGGCTGATCCCGCCGGGGCCGCTGCTGAGCGTCGCGGCCGAGGTTCTGGACGCCGAACTGGCGGTACTGGGGCTCTCCGCGCTGGCGAAACCGGCGAGGACGATCGACGTGTGCCCCGACAGCCTCCGGCCTTCGGACGGAGTGGCGACCGTGCCCATGCGGTACGTGCCCTACAACGGCCCGGCCGGCGTACCCGACTGGCTGTTGGCCGGGCCCCCTGCCCGGCCCCGGGTCTGCCTGACGCTGGGCACGTCCCTGCCCCGGCGTGATCCGCACGTGGCACCGCTGTGGCGGCTGCTGCTGGATGAACTGGTGGCCCTGGGCCAAGAGGTGGTCATCGCCATCGACGAGAGCCACCGGCCCCTGCTGGGCCACCTGCCCGACGGCGTGCGCGCCGCCCGGATCCCGCTCTGCGACCTGCTGCCGACGTGCACCGCGATCGTGCACCACGGTGGCTCGGGGAGCACCATGGCGGCGGCCTCCTTCGGTGTGCCGCAGCTGGTGGTTCCGCACTTCGCGGACCACTTCACCAACGCGGAGCGACTCACCGCCGTCGGCGCGGGTCTGAGCCTGCCGCACGACACCGACGACCTGGCACGGATCAGCGCGGCCTGCGAGCTGATCACCGGAGACGGCCCGCACCGCGCGATCTCACGCCGTCTCGCCGACGAGAACGCCCGCCGACCGACCCCGGCCGTGGTGGCCGAGGGCCTGGCGGCCGAACAACGGTCAATGACTCCCGCGTGA	MRVLLTSLPGIGHLFPMVPLGWALQAAGHTVLVATDREFLPVVTGAGLSATAVLDPVDPVELFKPVEPFGDPLSPAERTGHRCAEAGVRALPAMRALVDVWHPDLVIAEPMELAGPAAATNAGVPWVRHSYGLIPPGPLLSVAAEVLDAELAVLGLSALAKPARTIDVCPDSLRPSDGVATVPMRYVPYNGPAGVPDWLLAGPPARPRVCLTLGTSLPRRDPHVAPLWRLLLDELVALGQEVVIAIDESHRPLLGHLPDGVRAARIPLCDLLPTCTAIVHHGGSGSTMAAASFGVPQLVVPHFADHFTNAERLTAVGAGLSLPHDTDDLARISAACELITGDGPHRAISRRLADENARRPTPAVVAEGLAAEQRSMTPA	MTSEHRSASVTPRHISFFNIPGHGHVNPSLGIVQELVARGHRVSYAITDEFAAQVKAAGATPVVYDSILPKESNPEESWPEDQESAMGLFLDEAVRVLPQLEDAYADDRPDLIVYDIASWPAPVLGRKWDIPFVQLSPTFVAYEGFEEDVPAVQDPTADRGEEAAAPAGTGDAEEGAEAEDGLVRFFTRLSAFLEEHGVDTPATEFLIAPNRCIVALPRTFQIKGDTVGDNYTFVGPTYGDRSHQGTWEGPGDGRPVLLIALGSAFTDHLDFYRTCLSAVDGLDWHVVLSVGRFVDPADLGEVPPNVEVHQWVPQLDILTKASAFITHAGMGSTMEALSNAVPMVAVPQIAEQTMNAERIVELGLGRHIPRDQVTAEKLREAVLAVASDPGVAERLAAVRQEIREAGGARAAADILEGILAEAG	89.39	gnl|BL_ORD_ID|1723|hsp_num:0	1824		
BGC0000834.1|Novobiocin_11 # 10416 # 12449 # 1 # ID=1_11;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.681	BGC0000834.1|Novobiocin_11 	10416	12449	+	Loose	600	26.1794	vanHB	30.91	3002943	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	vanH; glycopeptide resistance gene cluster	ATGCTCATTCTTGGCCTGAACGGGAATGTGTCCGCAGCGGGCGCCGATGTGGTGCCGAACCTCAACGAGCTCTACATGCACGACGCCGCCGCCACACTGGTCCGCGACGGAGTTCTCGTGGCGGCGGTGGAGGAGGAGCGGCTCAACCGGATCAAGAAGACGACGAAATTCCCCAGCAACGCGATCCGGGAATGCCTCGCCGCCGCGGGTGCGAAACCGGCGGACGTCGACGCGATCGCCTACTACTTCCCCGAAGACTTCTTCGACGACATATTCCAGCAGCTCTACACCGAGCATCCGAGCGTGCCGACGCGGTACTCGCGCGAGATGATCCTGGAGCGTCTTCGCGTCGACCTCGGCTGGGCGGCTCCGCCGGACATCCTCCACTACGTGCCGCACCACCTGGCCCACGCGATGTCGACGTACTACCGGTCGGGCATGCGCGAGGCACTGGTCGTCGTCATGGACGGGGCGGGTGAGCGCAACTGCACCACGATCTACCGGTCGGACGGGGCCGAGCTGTTCGAGATCGCGTCGTACCCGGTGCCGAAGTCGCTCGGCATGTTCTACCTGTACGGGACCAGACACCTCGGCTACGGCTTCGGCGACGAGTACAAGGTGATGGGCCTCGCCCCGTACGGCGACCCGTCCACCTACCGCGACGTCTTCTCGACCCTGTACTCGCTCGGTCCGAACGGCACCTACGAGTTGATCCCGCGCGGGGGAGTGGTCTTCAGGATGACCACGATCCTGCGGGAGCACGGTCTCCAACCCCGCCGTCGCGGTGAGCCGTTCACCCAGGCGCACATGGACTTCGCGGCGAGTGTGCAGGAGACCACCGAGCAGATCGCGATGCACGTGATCGGCTACTGGGCACGCTCCACGGGCCTGCGGAACCTGGCCTTCGGTGGCGGCGTCGCCCACAACTCGACGCTCAACGGCCGCATCCTCACCTCCGGCCTGTTCGACGAGGTGTTCGTCCATCCGGCGTCGCACGACGCCGGATCCAGCGAGGGCGCCGCACTCGTGGTCGCGCGGGAACGCGGCGAACGCGTATGGCCGCTGCCCCGGTTGACGAACGCGAGCCTCGGCCCGGATCTGGGCGACGTCGACTCGCTGGAGCGGACGCTCAAGTCGTGGAGCCCGCTCGTCGACGTCGAGCGTCCCGACGACATCGTCGAGGCCACCGCGCACCTGCTCGCTGCCGGCGAGGCGATCGGCTGGGCGCACGGCCGCTCGGAGTTCGGGCCGCGCGCGCTGGGCAACCGCAGCATCCTCGCCGACGCGCGCCCCAAGGAGAACCAGACGCGCATCAACGCCATGGTGAAGAAGCGCGAGAGCTTCCGCCCGTTCGCCCCGGTCGTGACCGCGGAGGCGGCCGGTGACTACTTCGATCTGCCGGAGACCGTGGGACACCACGACTTCATGTCGTTCGTCGTGCAGGTGCGGGCGGACCGCCGGGAGTTGCTCGGCGCGGTGACCCATGTCGACGGCAGCGCGCGCGTCCAGGTCGTCACCGAGGAGACGAACCCGCGATTCCACCGGCTCGTCACGCGCTTCGGTGAGTTGACCGGCACCCCCGTGCTGCTCAACACCTCGTTCAACAACCACGCCGAGCCGATCGTGCAGTCCGTCGATGACGTCCTCACGAGCTATCTCACGACGAGCCTCGACGTGCTCGTGATCGAGGACTTCGTGGTTCGCAGGCGGACCGAACTGCCGCTGGCGCTGGAGGACTTCACCATCGGCTTTCGCCCGGTGACCAGGCTCGTCCGCCGGCTCGCCGACGTGTCGGCGGGCAGGCCGGGCGCTCCCGAGGTCTCGCACGAGATCTACCTCGACCACACCTCCGGACCGCGTGCGACGATCTCGGCCGCCATGTACGAGCTGCTCACCCACGCCGACGGTGTCACCCCGCTGGGCAGCCTCGGCATCGAGCTGACCGGAGAGCTCCTGACAGAGCTGTACGACCTGTGGCAGGGGCGCTTCGTCACCGTCGCCCCCGTGGGGGACGGTGCCGGATCCGCACCGTGA	MLILGLNGNVSAAGADVVPNLNELYMHDAAATLVRDGVLVAAVEEERLNRIKKTTKFPSNAIRECLAAAGAKPADVDAIAYYFPEDFFDDIFQQLYTEHPSVPTRYSREMILERLRVDLGWAAPPDILHYVPHHLAHAMSTYYRSGMREALVVVMDGAGERNCTTIYRSDGAELFEIASYPVPKSLGMFYLYGTRHLGYGFGDEYKVMGLAPYGDPSTYRDVFSTLYSLGPNGTYELIPRGGVVFRMTTILREHGLQPRRRGEPFTQAHMDFAASVQETTEQIAMHVIGYWARSTGLRNLAFGGGVAHNSTLNGRILTSGLFDEVFVHPASHDAGSSEGAALVVARERGERVWPLPRLTNASLGPDLGDVDSLERTLKSWSPLVDVERPDDIVEATAHLLAAGEAIGWAHGRSEFGPRALGNRSILADARPKENQTRINAMVKKRESFRPFAPVVTAEAAGDYFDLPETVGHHDFMSFVVQVRADRRELLGAVTHVDGSARVQVVTEETNPRFHRLVTRFGELTGTPVLLNTSFNNHAEPIVQSVDDVLTSYLTTSLDVLVIEDFVVRRRTELPLALEDFTIGFRPVTRLVRRLADVSAGRPGAPEVSHEIYLDHTSGPRATISAAMYELLTHADGVTPLGSLGIELTGELLTELYDLWQGRFVTVAPVGDGAGSAP	MRKSMGITVFGCEQDEANAFRTLSPDFHIIPTLISDAISADNAKLAAGNQCISVGHKSEVSEATILALRKVGVKYISTRSIGCNHIDTTAAERMGISVGTVAYSPDSVADYALMLMLMAIRGAKSTIHAVAQQNFRLDCVRGKELRDMTVGVIGTGHIGQAVVKRLRGFGCRVLAYDNSRKIEADYVQLDELLKNSDIVTLHVPLCADTRHLIGQSEIGEMKQGAFLINTGRGALVDTGSLVEALGSGKLGGAALDVLEGEDQFVYTDCSQKVLDHPFLSQLLRMPNVIITPHTAYYTERVLRDTTEKTIRNCLNFERSLQHE	209.60	gnl|BL_ORD_ID|586|hsp_num:0	626		
BGC0000834.1|Novobiocin_12 # 12446 # 12625 # 1 # ID=1_12;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.611	BGC0000834.1|Novobiocin_12 	12446	12625	+	Loose	1650	20.7866	Streptococcus agalactiae mprF	30.56	3003774	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	defensin resistant mprF	GTGAATGGTGCGGATCCGGGCCGGGAATGGGCCGTCGCGGCCGTACAACTGCCCTTTCATTTCGGAATACACCGGCCCTGTGTCCGTGTAGGCTCAATTCAGGATTTATCGGCGGCGGTCGGAGGAAGTCGGCGAGTGTGGAATGTCAGCCACCGCCGACCTCAATTTCCCCCACCGTGA	MNGADPGREWAVAAVQLPFHFGIHRPCVRVGSIQDLSAAVGGSRRVWNVSHRRPQFPPP	MLKKLIEKVKSLTSVIKIVFFISVLVLIIVEMIHLKRTISVEQLKSVFGQLSPMNLFLIILVGVIAVLPTTGYDFVLNGLLRTDKSKRYILQTSWCINTFNNLSGFGGLIDIGLRMAFYGKKGQEKSDLREVTRFLPYLISGLSFISVIALIMSHIFHAKASVDYYYLVLIGASMYFPVIYWISGHKGSHYFGDMPSSTRIKLGVVSFFEWGCAAAAFIIIGYLMGIHLPVYKILPLFCIGCAVGIVSLIPGGLGSFELVLFTGFAAEGLPKETVVAWLLLYRLAYYIIPFFAGIYFFIHYLGSQINQRYENVPKELVSTVLQTMVSHLMRILGAFLIFSTAFFENITYIMWLQKLGLDPLQEQMLWQFPGLLLGVCFILLARTIDQKVKNAFPIAIIWITLTLFYLNLGHISWRLSFWFILLLLGLLVIKPTLYKKQFIYSWEERIKDGIIIVSLMGVLFYIAGLLFPIRAHITGGSIERLHYIIAWEPIALATLILTLVYLCLVKILQGKSCQIGDVFNVDRYKKLLQAYGGSSDSGLAFLNDKRLYWYQKNGEDCVAFQFVIVNNKCLIMGEPAGDDTYIREAIESFIDDADKLDYDLVFYSIGQKLTLLLHEYGFDFMKVGEDALVNLETFTLKGNKYKPFRNALNRVEKDGFYFEVVQSPHSQELLNSLEEISNTWLEGRPEKGFSLGYFNKDYFQQAPIALVKNAEHEVVAFANIMPNYEKSIISIDLMRHDKQKIPNGVMDFLFLSLFSYYQEKGYHYFDLGMAPLSGVGRVETSFAKERMAYLVYHFGSHFYSFNGLHKYKKKFTPLWSERYISCSRSSWLICAICALLMEDSKIKIVK	6.97	gnl|BL_ORD_ID|2111|hsp_num:0	2283		
BGC0000834.1|Novobiocin_13 # 12680 # 13372 # 1 # ID=1_13;partial=00;start_type=ATG;rbs_motif=AGGGG;rbs_spacer=7bp;gc_cont=0.674	BGC0000834.1|Novobiocin_13 	12680	13372	+	Loose	600	35.8094	emtA	46.15	3004669	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic	antibiotic target alteration	non-erm 23S ribosomal RNA methyltransferase (G748)	ATGAAGATTGAAGCGATTACGGGATCCGAGGCCGAAGCATTTCACCGGATGGGGTCCCAGGCGTCCCACAGGTACGACGAATTCGTGGATCTGCTTGTCGGGGCCGGCATCGCCGACGGCCAGACCGTGGTCGACCTGTGCTGTGGCTCGGGCGAGCTGGAAGTCATCCTCAGCTCCCGGTTCCCCTCGCTGAATCTGGTCGGTGTCGACCTCTCGGAGGACATGGTCCGTATCGCCCGGGAGTACGCGGCCGAGCAGGGCAAGGCGCTCGAATTCCGGCACGGCGACGCGCAACTCCTGGCCGGTATGGAGGATCTGGCCGGGAAAGCGGACCTGGTGGTCTCGCGGAACGCGTTCCACCGGCTCACCCGGCTGCCGGCGGCGTTCGACACCATGCTGCGCCTGGCCAAGCCGGGAGGGGCCGTCCTCAACTGCTCCTTCATACACCCGAGCGACTTCGACGAGTCCGGGTTCCGGGCGTGGGTCACGTTCCTCAACCAGCGGCCCTGGGACTCGGAGATGCAGATCGTCTGGGCGCTGGCTCACCATTACGCGCCCCGGCTCGACGACTACCGCGAGGCCCTGGCCCAGGCGGCCCGTGAGACGCCGGTGTCCGAGCAGCGCGTCTGGATCGACGACCAGGGATACGGCGTTCCCACGGTCAAATGCTTCGCCCGCCGGGCCGCCGCCTGA	MKIEAITGSEAEAFHRMGSQASHRYDEFVDLLVGAGIADGQTVVDLCCGSGELEVILSSRFPSLNLVGVDLSEDMVRIAREYAAEQGKALEFRHGDAQLLAGMEDLAGKADLVVSRNAFHRLTRLPAAFDTMLRLAKPGGAVLNCSFIHPSDFDESGFRAWVTFLNQRPWDSEMQIVWALAHHYAPRLDDYREALAQAARETPVSEQRVWIDDQGYGVPTVKCFARRAAA	MTLYFASVLSGLEYVLSNEINNKVSDSEIIQINRGKVFFTTAESFTCLSSLRSADHLFQVIDQFQIGPHKKHLSQVSERISQLDLEFIDHKDLFWVNASRKGKQTYSRFELAKKAMEGINKRYPDWNIGTSQNHQIEFRLDIEHHNVIFSLRLTDATFRFRNQTRRFSRASLLPSVAHAMVWLSDPESKDVFVDFCCGSGTILSERATYPANQIIGGDISEAVTKIAKSNLDDSKVQVNVWDARKLPFSTGCVDKIVTNLPFGRQISPDEDLELFNHHIMIEVCRVLKPNGRAVILSESVNQLFWEAKRLGLFCLESYPLSLKGVNPTLFVFEKQDGLRRK	67.45	gnl|BL_ORD_ID|2272|hsp_num:0	3368		
BGC0000834.1|Novobiocin_14 # 13429 # 14205 # 1 # ID=1_14;partial=00;start_type=GTG;rbs_motif=GGGGT;rbs_spacer=10bp;gc_cont=0.631	BGC0000834.1|Novobiocin_14 	13429	14205	+	Loose	500	28.1054	OXA-243	23.08	3001610	protein homolog model	n/a	n/a	cephalosporin; penam	antibiotic inactivation	OXA beta-lactamase	GTGGAAACCGCGAAGGAAACGAACAGCGACTCATCGCTGTATCTGGACCTCATGATCAAAGTGCTGGCCGGGACGGTGTACGAGGATCCCGCGCACCGGGAGAACTTCTCGCACCGCGATTCGACGTACCGGGAAGAAGTCCGCAACGAGGGACGCGACTGGCCCGCGAACGCACACACGATGATCGGAATCAAACGCCTCGAGAACATCCGGCAATGTGTCGAGGACGTCATCGGCAACAACGTACCCGGCGACCTCGTGGAAACCGGCGTATGGCGTGGGGGAGCCTGCATCCTCATGCGGGGAATTCTGCGCGCCCATGACGTGCGGGACCGCACAGTCTGGGTCGCCGACTCCTTCCAGGGCATTCCCGACGTCGGTGAGGACGGCTACGCCGGCGACCGGAAGATGGCGCTGCACCGGCGAAACTCGGTGCTCGCGGTCTCCGAGGAAGAGGTCCGGCGCAACTTCCGCAACTACGACCTGCTGGACGAACAGGTCCGGTTCCTTCCCGGCTGGTTCAAGGACACGCTGCCCACCGCGCCGATCGACACGCTCGCCGTGCTGCGGATGGACGGGGACCTGTACGAATCCACCTGGGACACCCTGACCAATCTCTACCCGAAGGTGTCCGTCGGTGGCTATGTCATCGTCGACGACTACATGATGTGCCCGCCGTGCAAGGACGCGGTCGACGAATACCGCGCGAAGTTCGACATCGCCGACGAACTGATCACGATCGACCGCGACGGTGTCTACTGGCAACGCACCCGGTAA	METAKETNSDSSLYLDLMIKVLAGTVYEDPAHRENFSHRDSTYREEVRNEGRDWPANAHTMIGIKRLENIRQCVEDVIGNNVPGDLVETGVWRGGACILMRGILRAHDVRDRTVWVADSFQGIPDVGEDGYAGDRKMALHRRNSVLAVSEEEVRRNFRNYDLLDEQVRFLPGWFKDTLPTAPIDTLAVLRMDGDLYESTWDTLTNLYPKVSVGGYVIVDDYMMCPPCKDAVDEYRAKFDIADELITIDRDGVYWQRTR	MTVRLSSTALGAALSLSALAGAPAQAAVLCTVVADAADGRIVYQQGTQQACAARYTPASTFKLPIALMGADAGILTGPHAPVWNYQPGYPDWGGDAWRQPTDPARWIKYSVVWYSQLTARALGQERFQRYASAFHYGNEDVSGEPGKHNGLDGAWINSSLRISPLEQLAFLRKLVNRQLPLKAAAYDLAENLFEVGEAGGWHLYGKTGTGSPGSNGVYTAANAYGWFVGWARKDGRQLVFARLVQDEQATKPNAGLRARDDLMRDWPAMADAPRK	93.82	gnl|BL_ORD_ID|615|hsp_num:0	655		
BGC0000834.1|Novobiocin_15 # 14235 # 15206 # 1 # ID=1_15;partial=00;start_type=ATG;rbs_motif=AGG;rbs_spacer=5bp;gc_cont=0.691	BGC0000834.1|Novobiocin_15 	14235	15206	+	Loose	500	25.409	OXA-114a	30.26	3001609	protein homolog model	n/a	n/a	cephalosporin; penam	antibiotic inactivation	OXA beta-lactamase	ATGCCCGCACTCCCGATGAATCAAGAATTCGACCGCGAACGCTTTCGCGTCGATTTACGCGCCACCGCCGCCGCGATCGGCGCGCCCGTCACCCCCCGTGTCACCGACACGGTCCTCGAGACCTTCCGTGACAACTTCGCCCAGGGCGCCACCCTGTGGAAGACCACCAGCCAGCCCGGGGACCAGCTGTCGTACCGGTTCTTCTCCCGTCTCAAGATGGACACCGTCGGCCGGGCCGTCGACGCCGGGCTGCTCGACGGCACACATCCGACCGTGCCCATCGTCGAGGACTGGAGCGACCTCTACGGCGGCACGCCCGTGCAGTCGGCCGACTTCGACGCCGGGCGGGGAATGGCCAAGACCTGGCTGTACTTCGGCGGCCTGCGGCCGGCCGAGGACATCCTCTCCGTCCCCGCACTGCCGGCGCCGGTACAGGCCCGGCTGAAGGACTTCCTCGGACTGGGCCTGGCACATGTCCGGTTCGCGGCGGTGGACTGGCGCCACCGGAGTGCGAACGTCTACTTCCGCGGTCAAGGCCCCCTGGACACCGCTCAGTTCGCCCGCGTCCACGCCCTGTCCGGCGGCACACCACCCGCCGCGGATGTCGTGGCGGAGGTCCTCGCGTACGTGCCCGAGGACTACTGCGTCGCCATCACCCTCGACCTGCACACCGGCGCCATCGACCGGGTGTGCTTCTACGCCCTGAAGGTCCCCAAGGACGCGCGGCCACGCGTCCCCGCCCGCATCGCCACGTTCCTCGAGGTCGCGCCCAGCCACGACCCGGAGGAGTGCAACGTCATCGGCTGGTCGTTCGGCCGCAGCGGCGACTACGTCAAGGCCGAACGCAGCTACACCGGGAACATGACGGAGATCCTGTCCGGCTGGAACTGCTTCTTCCACGGCGAGGAAGGCCGCGACCACGACCTGCGCGCGCTTCAAGACACCGGATCGATCACCGGAGGTGCCCGATGA	MPALPMNQEFDRERFRVDLRATAAAIGAPVTPRVTDTVLETFRDNFAQGATLWKTTSQPGDQLSYRFFSRLKMDTVGRAVDAGLLDGTHPTVPIVEDWSDLYGGTPVQSADFDAGRGMAKTWLYFGGLRPAEDILSVPALPAPVQARLKDFLGLGLAHVRFAAVDWRHRSANVYFRGQGPLDTAQFARVHALSGGTPPAADVVAEVLAYVPEDYCVAITLDLHTGAIDRVCFYALKVPKDARPRVPARIATFLEVAPSHDPEECNVIGWSFGRSGDYVKAERSYTGNMTEILSGWNCFFHGEEGRDHDLRALQDTGSITGGAR	MTVRRLSCALGAALSLSALGGGPVQAAVLCTVVADAADGRILFQQGTQQACAERYTPASTFKLAIALMGADAGILQGPHEPVWNYQPAYPDWGGDAWRQPTDPARWIKYSVVWYSQLTAKALGQDRFQRYTSAFGYGNADVSGEPGKHNGTDGAWIISSLRISPLEQLAFLRKLVNRQLPVKAAAYELAENLFEAGQADGWRLYGKTGTGSPGSNGVYTAANAYGWFVGWARKDGRQLVYARLLQDERATRPNAGLRARDELVRDWPAMAGAWRP	117.45	gnl|BL_ORD_ID|1788|hsp_num:0	1892		
BGC0000834.1|Novobiocin_16 # 15203 # 16015 # 1 # ID=1_16;partial=00;start_type=ATG;rbs_motif=AGGT;rbs_spacer=5bp;gc_cont=0.691	BGC0000834.1|Novobiocin_16 	15203	16015	+	Loose	600	25.0238	ICR-Mc	28.26	3004466	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	intrinsic colistin resistant phosphoethanolamine transferase	ATGAGCGAGGCTCTGGCGAACATGCCCGGAGACGACTACTTCCGTCAGCCGCCGGTGTTCGACACCTACGCCGAGCACCGCGCCTATCTCAAGTTCCGGCACGCCGTCGCGCTGCGGCACTTCGCCCGCCTCGGCTTCGACCAGGACGGCCTCGCCGGACTGATCACCGTCGCCGACCCGGAACACGCCGACACCTACTGGGCCAATCCGCTGGCCCACCCCTTCTCCACCATCACACCGGCGGACCTGATCCGCGTCGACGGCGACAGCGCCGAGACCGTCGAAGGCCAACGCCGGGTCAACATCGCCGCGTTCAACATCCACGCCGAGATCCACCGCGCACGCCCCGACGTCCAGGCCGTCATCCACCTGCACACCGTCTACGGCCGAGCCTTCTCCGCCTTCGCCCGCAAGCTCCCTCCGCTGACCCAGGACGCGTGCCCGTTCTTCGAGGACCACGAGGTGTTCGACGACTTCACGGGTCTGGTGCTCGCCAAGGACGACGGGCGCAGGATCGCGAAACAGCTGCGCGGGCACAAGGCGATCCTGCTGAAGAACCACGGTCTGGTCACCGTCGGGGAGACACTCGACGCGGCCGCCTGGTGGTTCACGCTCCTGGACACCTGCTGCCATGTCCAGCTGCTGGCGGACGCGGCCGGGAAGCCGGAGGAGATCCCCGCGGAGGTCGCACGCCTGACGGGCCGGCAGCTCGGCTCGCACCTGCTGGGCTGGAACAGCTACCAGCCCCTGCACGAGGCAGCCCTGGCCCGTGACCCCGACCTGGCGACCATGGAGCCCGCGCTCCCGTCATGA	MSEALANMPGDDYFRQPPVFDTYAEHRAYLKFRHAVALRHFARLGFDQDGLAGLITVADPEHADTYWANPLAHPFSTITPADLIRVDGDSAETVEGQRRVNIAAFNIHAEIHRARPDVQAVIHLHTVYGRAFSAFARKLPPLTQDACPFFEDHEVFDDFTGLVLAKDDGRRIAKQLRGHKAILLKNHGLVTVGETLDAAAWWFTLLDTCCHVQLLADAAGKPEEIPAEVARLTGRQLGSHLLGWNSYQPLHEAALARDPDLATMEPALPS	MSLKHNQTHNTTFTKFLKSNSFWSKGFWSNRHHRTKDLKGLDAYLFMAIVAIFLTTTANVTFFQQVMSVYPLANYAPFIASLAVVLTGVLLLLLVLLGYRHTLKTVAICFILIAAFAGHFTDTYGTVYDTTMLQNALQTDTAETKDLLSMKLLIRVVLLAGLPICWIIGQPLSFGTLKASLMKRLVTYLVALALVGLPILAFSSQYASFFREHKPLRFFTNPVTVMYSAGKLANMSYKNATKPTETIMHANDAIQKTTASTRKPRLVVMVVGETARADHASFNGYQRATFPHMDKLIGLGQVHNFGNVTSCGTSTAYSVPCMFSYLGAEKYDVDTADYHENVIDTLDRLGVAILWRDNNSDSKGVMNRLPAKQYQDYKNSPLQGGNNTICHTNPYDECRDVGMLVDLDDHVKAHANQDILIVLHQMGNHGPAYYKRYDDEFAQFLPVCTSSELAECERQTVINAYDNALLATDDFLKQTIDWLAAQTHADTAMLYLSDHGESLGEKGVYLHGMPKAFAPKEQLSIPALLWLGADTPFAVANSPTAGFSHDAITPTLLNLFDVSTQATADKTAFVNPLD	46.71	gnl|BL_ORD_ID|2575|hsp_num:0	2902		
BGC0000834.1|Novobiocin_17 # 16048 # 16878 # 1 # ID=1_17;partial=00;start_type=ATG;rbs_motif=GGT;rbs_spacer=9bp;gc_cont=0.696	BGC0000834.1|Novobiocin_17 	16048	16878	+	Loose	2000	27.7202	Mycobacterium tuberculosis embA mutant conferring resistance to ethambutol	31.03	3003453	protein variant model	G350D	n/a	polyamine antibiotic	antibiotic target alteration	ethambutol resistant embA	ATGCTCGGGCGAGATCTGGTGGCGCTCCTGCGAGGGCTGAACGAACCGGTGGTCGCCATCACCCGGCACGATCTCGACATCACCGACCGCCTCTCGGTCCGGGCCGTTGTCGACAGGCACCGGCCGACGACCATCGTCAACTGCGCCGCCTGGACACGATTCGGCGAGGCGGAGGCCGGCGAATCGGCGGCCCTTCTCGTCAACGGAGGAGGGGCCCGGGAGCTGGCCGCGGTATGCCGTGATCGATCGATACGGCTGGTCCACCTCTCCACCGATTACGTCTTCGACGGCACGAGCCGCCGCCCCTACGCCGAAAGCGCGGTCACGAGCCCGATCAACGCGTACGGCCGGACGAAGCAGGCCGGCGAACAGGCGGTGCTCGACCTGCTGCCGGACGACGGCACGATCGTACGAACCGCCTGGCTGTACGGGCGGCACGGCATGAACTTCATCCGCAAGATGGTCCGGCTGGAGCAGCTGCGCGAGACCGTGGACGTGGTGGACGACCAGTGGGGCCAGCCGACCTGGACCGTGGATCTGGCACAGCAGATCGTGGCACTCGTCCGGCACGGTGCGTCCGGCGTGTTCCACGGAACGAGCGCGGGCGAGGCCACCTGGTACGACCTCGCCCGCATGACCTTCCGGCTGCTCGGCGCGGACCCCGGACGAGTGCGCCCGGTGCCCAGCGACCGGATCGCCGGCGGTGAACTGCGGCCCCGGTACACGGTGTTGGGGCATGACGCCTGGCGGGAGGCCGGGCTGACACCGATCCGGCACTGGACCACCGCTCTGACGCAGGCGTTCCCCCTGCTGAACGCCGATGAATCGTAG	MLGRDLVALLRGLNEPVVAITRHDLDITDRLSVRAVVDRHRPTTIVNCAAWTRFGEAEAGESAALLVNGGGARELAAVCRDRSIRLVHLSTDYVFDGTSRRPYAESAVTSPINAYGRTKQAGEQAVLDLLPDDGTIVRTAWLYGRHGMNFIRKMVRLEQLRETVDVVDDQWGQPTWTVDLAQQIVALVRHGASGVFHGTSAGEATWYDLARMTFRLLGADPGRVRPVPSDRIAGGELRPRYTVLGHDAWREAGLTPIRHWTTALTQAFPLLNADES	MPHDGNERSHRIARLAAVVSGIAGLLLCGIVPLLPVNQTTATIFWPQGSTADGNITQITAPLVSGAPRALDISIPCSAIATLPANGGLVLSTLPAGGVDTGKAGLFVRANQDTVVVAFRDSVAAVAARSTIAAGGCSALHIWADTGGAGADFMGIPGGAGTLPPEKKPQVGGIFTDLKVGAQPGLSARVDIDTRFITTPGALKKAVMLLGVLAVLVAMVGLAALDRLSRGRTLRDWLTRYRPRVRVGFASRLADAAVIATLLLWHVIGATSSDDGYLLTVARVAPKAGYVANYYRYFGTTEAPFDWYTSVLAQLAAVSTAGVWMRLPATLAGIACWLIVSRFVLRRLGPGPGGLASNRVAVFTAGAVFLSAWLPFNNGLRPEPLIALGVLVTWVLVERSIALGRLAPAAVAIIVATLTATLAPQGLIALAPLLTGARAIAQRIRRRRATDGLLAPLAVLAAALSLITVVVFRDQTLATVAESARIKYKVGPTIAWYQDFLRYYFLTVESNVEGSMSRRFAVLVLLFCLFGVLFVLLRRGRVAGLASGPAWRLIGTTAVGLLLLTFTPTKWAVQFGAFAGLAGVLGAVTAFTFARIGLHSRRNLTLYVTALLFVLAWATSGINGWFYVGNYGVPWYDIQPVIASHPVTSMFLTLSILTGLLAAWYHFRMDYAGHTEVKDNRRNRILASTPLLVVAVIMVAGEVGSMAKAAVFRYPLYTTAKANLTALSTGLSSCAMADDVLAEPDPNAGMLQPVPGQAFGPDGPLGGISPVGFKPEGVGEDLKSDPVVSKPGLVNSDASPNKPNAAITDSAGTAGGKGPVGINGSHAALPFGLDPARTPVMGSYGENNLAATATSAWYQLPPRSPDRPLVVVSAAGAIWSYKEDGDFIYGQSLKLQWGVTGPDGRIQPLGQVFPIDIGPQPAWRNLRFPLAWAPPEADVARIVAYDPNLSPEQWFAFTPPRVPVLESLQRLIGSATPVLMDIATAANFPCQRPFSEHLGIAELPQYRILPDHKQTAASSNLWQSSSTGGPFLFTQALLRTSTIATYLRGDWYRDWGSVEQYHRLVPADQAPDAVVEEGVITVPGWGRPGPIRALP	25.23	gnl|BL_ORD_ID|2009|hsp_num:0	1354		
BGC0000834.1|Novobiocin_18 # 16912 # 17922 # 1 # ID=1_18;partial=00;start_type=ATG;rbs_motif=AGGGG;rbs_spacer=6bp;gc_cont=0.672	BGC0000834.1|Novobiocin_18 	16912	17922	+	Loose	1200	28.4906	arnA	22.57	3002985	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	pmr phosphoethanolamine transferase	ATGCGAATTCTGGTGACGGGCGGCGCCGGCTTCATCGGCTCGGAATTCGTCCGGGCCACCTTGCGCGGAACTCTGCCGGGCTCATCGGGAACTCAGGTCACCGTTCTGGACAAGTTGACGTACTCCGGCAACGTGCTGAACCTCGCGCCGATCGCGGACCTGCGCAACTACCGTTTCGTGCGGGGCGACATCTGTGATCAGGACCTGGTGGACGACGTGGTCGCCGGTCACGACGCGATCGTGCACTTCGCCGCCGAGACACATGTGGACCGCTCGATCGGCAGCGCCGCCTCGTTCGTCCGCACGAACGCGATGGGCACCCAGGTACTGCTCGAAGCGGCCTCCCGCCACCGGCTGGGACGGTTCGTTCACATCTCGACCGACGAGGTGTACGGATCGATCCCCGAGGGCGCCTGGGACGAGGAGTCCCCGGTGGCCCCGAACGCCCCGTACGCGGCGGCCAAGGCGGCGGGAGACCTGCTGGCGCTGGCCTGGCACCGGACCCACGGGCTCGACGTCGTGGTCACCAGGTGCACCAACAACTACGGGCCGTACCAGTATCCGGAGAAGCTGATCCCGCTGTTCACGACCAACGTGATGGACGGTCAGCAGGTCCCGGTGTACGGCGAGGGCCACAACCGCCGGCAGTGGCTGCACGTCTCGGACCACTGCCGCGCCATCCAGCTGGTGCTCCTCGGTGGCCGGGCCGGGGAGGTCTACCACATCGGCGGTGGCACCGAGTTGACCAATCTCGAACTGGCCGAACAGATCCTGAAGTCCTGCGGTGCCGGCTGGGACATGGTCCGGCACGTGCCGGACAGGCCGGGGCACGATTTCCGCTACTCCCTGGACACCACCAAGATCCGTACAGAACTCGGTTTCTCGCCCCGGGTCGCGTTCGCGGACGGGCTGGTGGAGACCGTGGAGTGGTATCGCGACAACCGGGCCTGGTGGGAACCGCTCAAGAGTCCCGACGAAGCCACGGGTTCACCCGGCGACGCCGGCAGATGA	MRILVTGGAGFIGSEFVRATLRGTLPGSSGTQVTVLDKLTYSGNVLNLAPIADLRNYRFVRGDICDQDLVDDVVAGHDAIVHFAAETHVDRSIGSAASFVRTNAMGTQVLLEAASRHRLGRFVHISTDEVYGSIPEGAWDEESPVAPNAPYAAAKAAGDLLALAWHRTHGLDVVVTRCTNNYGPYQYPEKLIPLFTTNVMDGQQVPVYGEGHNRRQWLHVSDHCRAIQLVLLGGRAGEVYHIGGGTELTNLELAEQILKSCGAGWDMVRHVPDRPGHDFRYSLDTTKIRTELGFSPRVAFADGLVETVEWYRDNRAWWEPLKSPDEATGSPGDAGR	MTSKAVVFAYHDIGCTGIEALLNAGYEIAAVFTHADDPRENTFYASVARLCAERGIPLHAPEDVNHPLWLERIRQLRPDFLFSFYYRRLLGAELLACAARGAYNLHGSLLPRYRGRAPANWVLVNGETQTGVTLHRMIERADAGPILAQQAVAIDPEDTALSLHGKLRKAAGALLRDSLPLLALGVLPEVEQDESQASHFGRRTPADGLLDWHRPARQLYDLVRAVTQPYPGAFCQVGEQKLIVWSAEVVAGNHGREPGSVLSCDPLRIACGEDSLVLRFGQRGERGLYLAGTQLATELGLVEGARLRGAACSPQRRTRVLILGVNGFIGNHLSERLLRDGRYEVHGMDIGSDAIERLKADPHFHFVEGDIGIHSEWLEYHVKKCDVILPLVAIATPIEYTRNPLRVFELDFEENLRIVRYCVKYGKRVVFPSTSEVYGMCQDPDFDEDRSNLVVGPINKQRWIYSVSKQLLDRVIWAYGQQGLRFTLFRPFNWMGPRLDRLDSARIGSSRAITQLILHLVEGTPIRLVDGGAQKRCFTDVDDGIEALARIIDNRDGRCDGQIVNIGNPDNEASIRQLGEELLRQFEAHPLRAQFPPFAGFREVESRSFYGDGYQDVAHRKPSIDNARRLLDWQPTIELRETIGKTLDFFLHEALREREAQA	50.76	gnl|BL_ORD_ID|1549|hsp_num:0	1643		
BGC0000834.1|Novobiocin_19 # 17974 # 19236 # 1 # ID=1_19;partial=00;start_type=ATG;rbs_motif=AGGGG;rbs_spacer=9bp;gc_cont=0.652	BGC0000834.1|Novobiocin_19 	17974	19236	+	Loose	500	33.113	ErmD	28.85	3000495	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic; streptogramin antibiotic	antibiotic target alteration	Erm 23S ribosomal RNA methyltransferase	ATGCAGGACATAGTGCGGCCCATCGACGAGTGCCGGGTGTGCGGACACGACGATTGGCTCGATGTCGTCTCGTTCGGGTCGACGCCACTGGCCGGAAACCTGCTCGGCGACGAAGACGACGCGGGGGGCGAGACCCTGTTCCCGCTGGACGTCGTGGTGTGCCGGCGATGCTGGCTGATGACGCTGCGCCATGTCATCGAACCGGACGTCCTCTTCGGTCACTACCGTTACGTCGCCTCGGACGCGGGCTCGATCATCCAGCACATGCGGAAGCTCGTCGACCTGTGTGTCGAGCGGATCGGACTGACCGACGGAGACCTCGTCGTGGAGTTCGGCAGCAACACCGGCGCGCATCTGGAGCTGTTCCGGCAGGCCGGCCCCCGGGTGGTCGGCGTCGATCCCGCGCGCAATCTCGCGGGTGTCGCCAACGACCGCGGCGTGGAAACGATCCCCGCCGGTTTCACCGCCGAAGTCGGTGAGGAGATCGCGACCAGGCACGGCCTGGCACGACTGGTGTACGGGCGCCAGTGCTTCGCCCATATCCCGGACATCCACGAAGTCCTCAACGGGGTATCGGCCCTGCTGGCTCCAGACGGTCTGTTCTTCGTGGAAGTTCCCTATCTGGTGGAACTGCTCAAGAACAATCAGTTCGACACCATCTTCCACGAACACTTCTCCTACTTTTCGCTCGGCTCCCTGTGCACGCTGTTCGAGTCGCACGGCCTGCGCGTCGTGGACGTCCATACGGCCGATGTGCACGGCGGCTCGATCGTGGTCTTCGCCGCCCCGGCCGCCGCCGACCACGAGGTGCGGCCGGCCGTCGCCGAGATGCTCGCGGAAGAGCGGAGCCAGGGCATCGCGGAGGAGCGGACCTACCGGGAGTTCGCCGATCGTACGGAACGGGTGCGCGCACAGATCCGGGAACTGGTACGCGGCGTGGTGGCGGACGGCAAGACCGTGGCGGGATACGGCGCACCGACCAAGGGCAGCGCACTGCTGGCCGCCTGCGGGCTCGGACATCAGGAGATCCGGTTCTGCAGCGACACAACCGTTCTCAAGCAGGGGAAAATACTTCCGGGGTCCAGAATTCCGATCTGGTCACCGGAACAGGCGGCCGGCCATGTACCGGACTACTACCTGCTGTTGGCCTGGAACTACGCACCGGAGATCATCGACAACGAGAAGGAATTCCTGGAGAACGGCGGCCGATTCATCGTTCCCATACCCGAACCGCGGGTGATATCGGCGGAGTCGACGCTGTGA	MQDIVRPIDECRVCGHDDWLDVVSFGSTPLAGNLLGDEDDAGGETLFPLDVVVCRRCWLMTLRHVIEPDVLFGHYRYVASDAGSIIQHMRKLVDLCVERIGLTDGDLVVEFGSNTGAHLELFRQAGPRVVGVDPARNLAGVANDRGVETIPAGFTAEVGEEIATRHGLARLVYGRQCFAHIPDIHEVLNGVSALLAPDGLFFVEVPYLVELLKNNQFDTIFHEHFSYFSLGSLCTLFESHGLRVVDVHTADVHGGSIVVFAAPAAADHEVRPAVAEMLAEERSQGIAEERTYREFADRTERVRAQIRELVRGVVADGKTVAGYGAPTKGSALLAACGLGHQEIRFCSDTTVLKQGKILPGSRIPIWSPEQAAGHVPDYYLLLAWNYAPEIIDNEKEFLENGGRFIVPIPEPRVISAESTL	MKKKNHKYRGKKLNRGESPNFSGQHLMHNKKLIEEIVDRANISIDDTVLELGAGKGALTTVLSQKAGKVLAVENDSKFVDILTRKTAQHSNTKIIHQDIMKIHLPKEKFVVVSNIPYAITTPIMKMLLNNPASGFQKGIIVMEKGAAKRFTSKFIKNSYVLAWRMWFDIGIVREISKEHFSPPPKVDSAMVRITRKKDAPLSHKHYIAFRGLAEYALKEPNIPLCVRLRGIFTPRQMKHLRKSLKINNEKTVGTLTENQWAVIFNTMTQYVMHHKWPRANKRKPGEI	146.34	gnl|BL_ORD_ID|1049|hsp_num:0	1117		
BGC0000834.1|Novobiocin_20 # 19298 # 20191 # 1 # ID=1_20;partial=00;start_type=TTG;rbs_motif=GGGGGT;rbs_spacer=6bp;gc_cont=0.671	BGC0000834.1|Novobiocin_20 	19298	20191	+	Loose	200	35.4242	FosX	26.67	3000198	protein homolog model	n/a	n/a	fosfomycin	antibiotic inactivation	fosfomycin thiol transferase	TTGAGGGGAATCCTGCTCGCGGGCGGTACCGGCTCCAGGCTGTGGCCGGTCACCCGCGCCATCTCCAAGCAGCTGATACCGGTCTTCGACAAGCCGATGATCTACTACCCGCTGACCACGCTGATGATGGCCGGCGTACGCGAGATACTCGTGATCACGCGCCCCGACGACCAGCGCCAGTTCCGTCATCTCCTCGGCGACGGCTCGCAACTGGGCCTGCGCCTCGAGTACGCCGTCCAGGAGCGGCCCGAGGGCATCGCGCAGGCGTTCGTCCTGGGCGCCGAGTTCATCGGCGACCAGTCGGTGGCCCTGGTCCTCGGGGACAACATCTTCCACGGCGCGGGCCTGGGAACCCGGCTGCGGCAGTACAACGACCCCGCCGGGGCCCGGATCTTCGCCTACGTCGTGGCCGACCCCAAGGCGTACGGGGTGGTGGAGTTCGACGAGGCCGGAAGGGCCGTCTCCATAGAGGAGAAGCCGGCGCGTCCCAAGTCGCGGTACGCCGTACCGGGGTTGTACTTCTACGACAACCGGGTGCTGGATGTCGTCCACGGCCTGGTGCCGAGCCGGCGCGGCGAACTGGAGATCACCGCCGTCAACGAAACGTATCTGAAGTGGGGCCAGTTGCGGGTCACCACGCTCGACCGGGGCACCGCCTGGCTGGACACGGGAACGTTCGCCTCCTTGGTCCAGGCATCGGAGTACGTACGAGTCGTGGAGGAACGGCAGGGCCTCAAGATCGGCTGCGTGGAGGAGGTCGCCTGGCGCTGCGGCTTCATCGGGAACGACCAGTTGCGGGATCTCAGCCGCCCGCTGCTCAAGAGCGGCTACGGCCGGTACCTCCTCGATCTGCTCGCCGATCACGAGGAGTTGAAGGAGGTGAAGCCGTCGTGA	MRGILLAGGTGSRLWPVTRAISKQLIPVFDKPMIYYPLTTLMMAGVREILVITRPDDQRQFRHLLGDGSQLGLRLEYAVQERPEGIAQAFVLGAEFIGDQSVALVLGDNIFHGAGLGTRLRQYNDPAGARIFAYVVADPKAYGVVEFDEAGRAVSIEEKPARPKSRYAVPGLYFYDNRVLDVVHGLVPSRRGELEITAVNETYLKWGQLRVTTLDRGTAWLDTGTFASLVQASEYVRVVEERQGLKIGCVEEVAWRCGFIGNDQLRDLSRPLLKSGYGRYLLDLLADHEELKEVKPS	MISGLSHITLIVKDLNKTTAFLQNIFNAEEIYSSGDKTFSLSKEKFFLIAGLWICIMEGDSLQERTYNHIAFQIQSEEVDEYTERIKALGVEMKPERPRVQGEGRSIYFYDFDNHLFELHAGTLEERLKRYHE	223.31	gnl|BL_ORD_ID|114|hsp_num:0	129		
BGC0000834.1|Novobiocin_21 # 20188 # 20811 # 1 # ID=1_21;partial=00;start_type=GTG;rbs_motif=AGGT;rbs_spacer=9bp;gc_cont=0.710	BGC0000834.1|Novobiocin_21 	20188	20811	+	Loose	700	23.8682	ACC-5	44.44	3001819	protein homolog model	n/a	n/a	monobactam; cephalosporin; penam	antibiotic inactivation	ACC beta-lactamase	GTGAGACTTCGCCCGCTCGGTATCGAGGGTGTCTGGGAGATCACCCCCGAGCAGCGCGCCGATCCGCGGGGGGTCTTCCTGGACTGGTATCACGTCGACCGGTTCGCCGAGGCGATCGGCCGCCCCCTGCGGCTGGCCCAGGCCAATCTGTCGGTGTCCGTCCGCGGGGTGGTGCGCGGCATCCACTTCGTCGATGTGCCGCCGGGGCAGGCCAAGTACGTGACGTGTGTGCGCGGCGCGGTGTTCGACGTGGTGGTGGACCTGCGCGTCGGCTCGCCGACGTACGGGTGCTGGGAAGGCACCCGGCTCGACGATGTCAGCCGTCGTGCCGTCTACCTCTCGGAGGGCATCGGGCACGGCTTCTGCGCGATCTCGGACGAGGCCACGCTGTGCTATCTGTCTTCGGGGACCTACGACCCGGCGACCGAGCACGGTGTGCACCCGCTCGATCCCGAACTGGCCATCGACTGGCCCACCGGGACGCCGCTGCTGTCCCCCCGCGACCAGGACGCGCTCCTGCTCGCCGAAGCCCGGGACGCCGGCCTGTTGCCGACCTACGCGACCTGTCAGGCCGTCACGGTGCCTTCACCGGCGCCGGGTTCGGTCGGAGACCCGGGCCCGTGA	MRLRPLGIEGVWEITPEQRADPRGVFLDWYHVDRFAEAIGRPLRLAQANLSVSVRGVVRGIHFVDVPPGQAKYVTCVRGAVFDVVVDLRVGSPTYGCWEGTRLDDVSRRAVYLSEGIGHGFCAISDEATLCYLSSGTYDPATEHGVHPLDPELAIDWPTGTPLLSPRDQDALLLAEARDAGLLPTYATCQAVTVPSPAPGSVGDPGP	MQNTLKLLSVITCLAATAQGALAANIDESKIKDTVDDLIQPLMQKNNIPGMSVAVTVNGKNYIYNYGLAAKQPQQPVTENTLFEVGSLSKTFAATLASYAQLSGKLSLDQSVSHYVPELRGSSFDHVSVLNVGTHTSGLQLFMPEDIKNTTQLMAYLKAWKPADAAGTHRVYSNIGTGLLGMIAAKSLGVSYEDAIEKTLLPQLGMHHSYLKVPADQMENYAWGYNKKDEPVHVNMEILGNEAYGIKTTSSDLLRYVQANMGQLKLDANAKMQQALTATHTGYFKSGEITQDLMWEQLPYPVSLPNLLTGNDMAMTKSVATPIVPPLPPQENVWINKTGSTNGFGAYIAFVPAKKMGIVMLANKNYSIDQRVTVAYKILSSLEGNK	53.63	gnl|BL_ORD_ID|1762|hsp_num:0	1865		
BGC0000834.1|Novobiocin_22 # 20773 # 21141 # -1 # ID=1_22;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.707	BGC0000834.1|Novobiocin_22 	20773	21141	-	Loose	2000	25.0238	Staphylococcus aureus mupB conferring resistance to mupirocin	29.41	3000510	protein homolog model	n/a	n/a	mupirocin	antibiotic target alteration	antibiotic-resistant isoleucyl-tRNA synthetase (ileS)	GTGCGGGAAGCAGCCGGAGAACTGGGGGGGAGAGGCGCGGCACGGCAGCCCGACCTGGGCCCCGGGGCTCGCGAAACCCTCGGGACGCCGGCCGCCGCCGACCATCGGGACGCTGAAGACAATACCGACGCCACCCCTTGCCGCCGGAACGAGAGCACCTCTGCGCGCCGCCGTGCGGCTCCCGCACCACATAAGTCGATCCCCCCTGCCTTCCCCTGTCGAAAAGACGGGAGAGGGCCGCCTGAAGGGTTCCCTGACGCCTTGCCGGACAGCGTCCCGGACACTATTTCCGACATGACCCTCCGCAGTCGCCAGTCGCGCTGCGTCAGATCACGGGCCCGGGTCTCCGACCGAACCCGGCGCCGGTGA	MREAAGELGGRGAARQPDLGPGARETLGTPAAADHRDAEDNTDATPCRRNESTSARRRAAPAPHKSIPPAFPCRKDGRGPPEGFPDALPDSVPDTISDMTLRSRQSRCVRSRARVSDRTRRR	MENENIIEEQKILNFWKEENIFKKSIDNRKNDNPFVFYDGPPTANGLPHTGHVLGRVIKDLFARYKTMQGFYVERKAGWDTHGLPVELGVEKKLGIKDKNEIEKYGIEKFINECKNSVFMYEKQWREFSELIGYWVDMEKPYKTMDNTYIESIWYILSDFHKKGLLYKGHKVTPYCPSCETSLSSHEVAQGYKEVKDISVILKFPILDSDENFLVWTTTPWSLPGNIALAINAEEIYVKVNYDNEIFIIMESLLQSVFKDEDNIDIVSKHKGKEFVGKEYLAPFPNKSLMNNENSYKVLPADFVTNKDGTGIVHIAPAYGEDDYKLVQENNIPFINVIDSRGKYNQDSPIFKGELAKESDINIIKELTHLNLLFKKEKYEHSYPFCWRCDNPLIYYAMEGWFIKTTAYKNEIKENNQKIEWYPDHIKNGRFGNFLDNMIDWNIGRKRYWGTPLNIWKCSTCSHEFSPKSINDLIQHSIEDIPSDIELHRPYIDNVKCKCQNCGGDMCREEEVIDVWFDSGSMPFAQNHYPFSGPIQNSYPADFIAEGVDQTRGWFYSLLVISTIFKGEAPYKNALSLGHILDSNGQKMSKSKGNVIDPISMIKTYGADSLRWTLVSDSVPWTNKRFSENMVAQSKSRVIDTLKNIFNFYNMYQKIDNYDYTRDTPKQLNLLDNWAISRMNSVIKEVELHLEKYNPTNASRAIGEFINEISNWYIRRSRSRFWSSEMNEDKKSAYFTLRLILINTCKIIAPFTPFTSEEIHLNLTKKSVHLEDFPQAKEEYINLKLEEDMNKVLDIVEKSRSIRNNINIKTKQPLSNMYIYDNNNLDNEFLRKYKDIIKDEINVKKINIVSDLDNFLEYDVKPNFSTLGPKLGKDMKQFQILFKNIKKEEMNKLINDFDKLQKVFDSLGVTIEEKDFIISKIPKKGFSLSSNDSDRLIILDTNLTQELIREGFVRELIRVIQQLRKQQNFNIEERINVVIDIDSDGLLSIKNNINILKENVLINNLKFEKRETMKYFKINQKEIGIQLMSSFTN	11.81	gnl|BL_ORD_ID|2124|hsp_num:0	2271		
BGC0000834.1|Novobiocin_23 # 21185 # 23218 # 1 # ID=1_23;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.681	BGC0000834.1|Novobiocin_23 	21185	23218	+	Loose	1000	654.055	Clostridioides difficile gyrB conferring resistance to fluoroquinolones	53.71	3004562	protein variant model	V423F	n/a	fluoroquinolone antibiotic	antibiotic target alteration	fluoroquinolone resistant gyrB	GTGACTTCTTACGACACCCGCACCGCCACCGACACCCCCGGACCCCAACTGCCCGGCCAGGTGGGGACGGCGTCGTACGACGCCGACGCGATCACCGTGCTGGACGGCCTGGACGCCGTACGCAAGCGGCCCGGGATGTACATCGGCTCCACGGGGGAGCGGGGGCTCCATCACCTGGTGCAGGAACTCGTGGACAACTCGGTGGACGAGGCACTCGCGGGGGTGGCCGACCGGATCGACGTGACGGTCCTGGCCGACGGCGGGGTGCGGGTGGTCGACAACGGCCGCGGCATCCCGGTGGGGATGCACCCGGTGGAGAAGCGGCCGGCCGTCGAGGTCGTACTGACCGTGCTGCACGCGGGCGGGAAGTTCGGGGGCGGCGGGTACACGGTCTCCGGCGGACTGCACGGCGTGGGTCTGTCGGTGGTCAACGCCCTGTCGGCCAGGCTGTCGGCGGAGATCTGGACGGACGGCCACCGCTGGACGCAGGACTACCGGGACGGCGCTCCCACCGCCCCACTGGTCCGCCGGGAGGCCACCTCCCGCACGGGCACCTCACTGACCTTCTGGGCGGACGGCTCCATCTTCGAGACCACCGACTACTCCTTCGAGACGCTGGCCAGGCGTTTCCAGGAGATGGCCTTCCTCAACCGTGGGCTCACGCTGACCCTCACCGACGAACGGGCCTCCGCGCGCGCCACGGCCGCGACCGACGAGGTCCACCCGGACCCGGCGGCGAAGACGGTCTCCTACCGCTACGACGGCGGCATCACCGACTTCGTCGCGTATCTCAACTCCCGCAAGGGCGAACCGGTCCATCCCTCGGTCGTCACCATCGCCGCCGACGACACGGAGCGGCTGCTGTCGGCCGAGATCGCGCTCCAGTGGAACGGCCAGTACACCGACAGCGTGTACTCGTACGCCAACGCGATCCACACCCACGAGGGCGGCACCCACGAGGAGGGCTTCCGTACGGCCCTGACCACCGTGGTCAACCGCTACGCGCGGGACAAGAAGCTGCTGCGGGAGAAGGACGCGAACCTCGCCGGCGAGGACATCCGTGAGGGGCTGACCGCGATCATCTCGGTCAAGCTCAGAGAACCGCAGTTCGAGGGCCAGACCAAGACCAAACTCGGCAACACGGAGGTGCGCACCTTCGTCCAGAAGGTCGTCCACGAGCATCTGACCGACTGGTTCGACCGCAACCCGAACGAGGCCGCGGACATCGTGCGCAAGGCCGTTCAGGCCGCCACGGCCCGGGTCGCGGCCCGTAAGGCGCGGGATCTGACCCGCCGTAAGGGCCTGCTGGAGACGGCGTCGCTGCCGGGCAAGCTGTCGGACTGTCAGTCGAACGACCCGGCGATGTCGGAGATCTTCATCGTCGAGGGAGACTCCGCCGGCGGCTCGGCCAAATCCGGCCGCAATCCGCAGTACCAGGCGATCCTCCCGATCCGGGGGAAGATCCTCAATGTCGAGAAGGCGCGGATCGACAGGATTTTGCAGAACCAGGAGATCCAGGCGCTCATCTCCGCGTTCGGCACGGGTATGCACGAGGACTTCGACATCGCCAAGCTCCGCTACCACAAGGTCATCTTGATGGCGGACGCCGACGTCGACGGCCAGCACATCAACACCCTGCTGCTGACCGTCCTGTTCCGCTTCATGCGGCCACTGATCGAGGAGGGGCACGTCTACCTCTCGCGCCCGCCGCTCTACAAGATCAAGTGGAGCCGGGACCACGTCGAGTACGCCTACTCCGACCGCGAACGCGACACGCTGCTGGAACTGGGCCGTCGGGACGGCCGCAGGGTCAGGGACGACTCCATCCAGCGCTTCAAGGGCCTCGGCGAGATGAACGCCGAGGAACTGCGCGTCACCACCATGGACCCCGACCACCGGGTGCTGGGGCGGGTCGCCCTCGACGACGCGGCCGTCGCCGACGACCTCTTCTCGGTTCTGATGGGTGAGGACGTGGAAGCCCGCCGCCACTTCATCCAGCGCAACGCCAAGGACGTCCGCTTCCTCGACATCTGA	MTSYDTRTATDTPGPQLPGQVGTASYDADAITVLDGLDAVRKRPGMYIGSTGERGLHHLVQELVDNSVDEALAGVADRIDVTVLADGGVRVVDNGRGIPVGMHPVEKRPAVEVVLTVLHAGGKFGGGGYTVSGGLHGVGLSVVNALSARLSAEIWTDGHRWTQDYRDGAPTAPLVRREATSRTGTSLTFWADGSIFETTDYSFETLARRFQEMAFLNRGLTLTLTDERASARATAATDEVHPDPAAKTVSYRYDGGITDFVAYLNSRKGEPVHPSVVTIAADDTERLLSAEIALQWNGQYTDSVYSYANAIHTHEGGTHEEGFRTALTTVVNRYARDKKLLREKDANLAGEDIREGLTAIISVKLREPQFEGQTKTKLGNTEVRTFVQKVVHEHLTDWFDRNPNEAADIVRKAVQAATARVAARKARDLTRRKGLLETASLPGKLSDCQSNDPAMSEIFIVEGDSAGGSAKSGRNPQYQAILPIRGKILNVEKARIDRILQNQEIQALISAFGTGMHEDFDIAKLRYHKVILMADADVDGQHINTLLLTVLFRFMRPLIEEGHVYLSRPPLYKIKWSRDHVEYAYSDRERDTLLELGRRDGRRVRDDSIQRFKGLGEMNAEELRVTTMDPDHRVLGRVALDDAAVADDLFSVLMGEDVEARRHFIQRNAKDVRFLDI	MMQEKKQTYDENQIQVLEGLEAVRKRPGMYIGSTSSRGLHHLVYEIVDNSIDEALAGYCDKINVIIHKDNSITVTDNGRGMPVGMHHKMKKPTVEVIMTILHAGGKFGGGGYKVSGGLHGVGASVVNALSEICEVEVKRESHIWRQVFKRGKVASGLDIIGDSEEHGTKIHFKPDAEIFDEIEYDYDTLAQRLRELAFLNKGIKIRLEDERDDKEEIFHYEGGIKSFVTYLNRNKQPIHKEPIYVEGKKDDYSVEIAIQYNDGYTENIFAFANNIDTVEGGTHLAGFKSALTRVFNDYAKKFGILKENDKNLSGEDIREGLTAVISVKLVDPQFEGQTKTKLGNSEVRGIVDSIMGESLNNFLQENPQVAKMILDKSLMASRAREAARKARELTRRKSILENTSLPGKLADCSSKDPSECEIYLVEGDSAGGSAKQGRNRKFQAILPLRGKIMNVEKQRLDKILGYEEIRAMITAFGAGIGKDFDVNKIRYNKIIIMTDADVDGAHIRTLLLTFFFRYMKELVEKCHVYIAQPPLYRVAKGKKEYYAYSDDELDVLLTEIGGKDSNVDIQRYKGLGEMDSEQLWDTTMNPETRTLIQVNVEDTMAADEIFTILMGDKVEPRRNFIQENAKKVVNLDI	106.28	gnl|BL_ORD_ID|2786|hsp_num:0	3268		
